High Falls Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,496
| Closed | -$482K | – | 117 |
|
|
2024
Q3 | $482K | Buy |
1,496
+6
| +0.4% | +$1.96K | 0.11% | 65 |
|
|
2024
Q2 | $466K | Buy |
1,490
+100
| +7% | +$29.4K | 0.11% | 63 |
|
|
2024
Q1 | $395K | Hold |
1,390
| – | – | 0.1% | 72 |
|
|
2023
Q4 | $400K | Sell |
1,390
-200
| -13% | -$54.5K | 0.11% | 65 |
|
|
2023
Q3 | $427K | Buy |
1,590
+100
| +7% | +$25K | 0.13% | 55 |
|
|
2023
Q2 | $331K | Hold |
1,490
| – | – | 0.09% | 75 |
|
|
2023
Q1 | $360K | Hold |
1,490
| – | – | 0.11% | 70 |
|
|
2022
Q4 | $391K | Sell |
1,490
-750
| -33% | -$201K | 0.12% | 71 |
|
|
2022
Q3 | $505K | Hold |
2,240
| – | – | 0.17% | 58 |
|
|
2022
Q2 | $545K | Sell |
2,240
-300
| -12% | -$73.5K | 0.17% | 60 |
|
|
2022
Q1 | $614K | Sell |
2,540
-5
| -0.2% | -$1.15K | 0.16% | 57 |
|
|
2021
Q4 | $572K | Sell |
2,545
-44
| -2% | -$9.29K | 0.15% | 64 |
|
|
2021
Q3 | $551K | Buy |
2,589
+1
| +0% | +$230 | 0.15% | 68 |
|
|
2021
Q2 | $631K | Hold |
2,588
| – | – | 0.17% | 63 |
|
|
2021
Q1 | $644K | Buy |
2,588
+1
| +0% | +$239 | 0.18% | 60 |
|
|
2020
Q4 | $595K | Buy |
+2,587
| New | +$596K | 0.17% | 61 |
|
|
2020
Q3 | – | Sell |
-2,941
| Closed | -$694K | – | 42 |
|
|
2020
Q2 | $694K | Buy |
2,941
+1
| +0% | +$228 | 0.26% | 46 |
|
|
2020
Q1 | $596K | Buy |
2,940
+1
| +0% | +$218 | 0.24% | 43 |
|
|
2019
Q4 | $708K | Buy |
2,939
+1
| +0% | +$220 | 0.2% | 51 |
|
|
2019
Q3 | $568K | Buy |
2,938
+1
| +0% | +$192 | 0.18% | 55 |
|
|
2019
Q2 | $541K | Sell |
2,937
-25
| -0.8% | -$4.48K | 0.18% | 53 |
|
|
2019
Q1 | $563K | Buy |
2,962
+28
| +1% | +$5.35K | 0.19% | 52 |
|
|
2018
Q4 | $571K | Sell |
2,934
-86
| -3% | -$16.8K | 0.22% | 42 |
|
|
2018
Q3 | $626K | Sell |
3,020
-862
| -22% | -$170K | 0.21% | 47 |
|
|
2018
Q2 | $717K | Sell |
3,882
-256
| -6% | -$45.3K | 0.25% | 38 |
|
|
2018
Q1 | $705K | Sell |
4,138
-47
| -1% | -$8.63K | 0.25% | 35 |
|
|
2017
Q4 | $728K | Sell |
4,185
-233
| -5% | -$41.2K | 0.26% | 35 |
|
|
2017
Q3 | $824K | Buy |
4,418
+1,391
| +46% | +$246K | 0.31% | 32 |
|
|
2017
Q2 | $521K | Buy |
3,027
+1
| +0% | +$163 | 0.2% | 40 |
|
|
2017
Q1 | $496K | Buy |
3,026
+1
| +0% | +$166 | 0.22% | 47 |
|
|
2016
Q4 | $442K | Buy |
3,025
+1
| +0% | +$151 | 0.2% | 45 |
|
|
2016
Q3 | $504K | Buy |
3,024
+303
| +11% | +$51.2K | 0.19% | 44 |
|
|
2016
Q2 | $442K | Sell |
2,721
-401
| -13% | -$62.3K | 0.13% | 61 |
|
|
2016
Q1 | $468K | Buy |
3,122
+401
| +15% | +$59.6K | 0.16% | 57 |
|
|
2015
Q4 | $442K | Buy |
+2,721
| New | +$428K | 0.13% | 61 |
|
Other funds holding AMGN
High Falls Advisors's AMGN Position: Q4 2024 in Review
High Falls Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,496 shares — an estimated $482K sold.
High Falls Advisors first reported a position in AMGN in Q4 2015 and held it in 35 quarters. The position peaked at $824K in Q3 2017. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- High Falls Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- High Falls Advisors sold 1,496 Amgen shares in Q4 2024, an estimated $482K.
- High Falls Advisors first reported a position in Amgen in Q4 2015 and held it in 35 quarters.
- High Falls Advisors's Amgen position peaked at $824K in Q3 2017.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on High Falls Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.